Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
How Can AI Transform Safety Event Reporting in Pharmaceuticals?
Research & Development How Can AI Transform Safety Event Reporting in Pharmaceuticals?

Pharmaceutical manufacturers are tasked with the critical responsibility of monitoring and reporting safety events to ensure patient safety and regulatory compliance. This process involves detecting, documenting, evaluating, reporting, and following up on adverse events, product quality complaints,

Can An Experimental Drug GL-II-73 Reverse Alzheimer's Memory Loss?
Research & Development Can An Experimental Drug GL-II-73 Reverse Alzheimer's Memory Loss?

Imagine a world where the devastating effects of Alzheimer's disease can be reversed through an innovative new drug. This scenario may soon become a reality, thanks to groundbreaking research from the Centre for Addiction and Mental Health (CAMH). The study investigates the impact of GL-II-73,

Phase I Trial Proves SABR Safe for Treating Extensive Metastatic Cancer
Research & Development Phase I Trial Proves SABR Safe for Treating Extensive Metastatic Cancer

Polymetastatic cancer, a condition where cancer has spread to more than 10 spots throughout the body, often leaves patients with limited treatment options. Recent advancements in cancer therapy have focused on high-precision radiation treatments to combat this extensive metastasis. Researchers from

UK Biotech Sector Sees Record Investments and Growth Amid Challenges
Management & Regulatory UK Biotech Sector Sees Record Investments and Growth Amid Challenges

The biotech and healthcare sectors in the United Kingdom experienced a remarkable year in 2024, marked by substantial financial investments, significant trends, and notable challenges. Grounded in a report by the UK BioIndustry Association (BIA), this analysis delves into the pivotal investment

3D-Printed Brain Model Enhances Neuron Growth Studies for Neurological Research
Biotech & Bioprocessing 3D-Printed Brain Model Enhances Neuron Growth Studies for Neurological Research

In a groundbreaking advancement for neuroscience, researchers at the Delft University of Technology (TU Delft) in the Netherlands have overcome a longstanding barrier in understanding neuron behavior and growth. Utilizing cutting-edge 3D printing techniques, the team has developed a brain-like

Can 10x Genomics Thrive in 2025 with New Products and Strategic Shift?
Management & Regulatory Can 10x Genomics Thrive in 2025 with New Products and Strategic Shift?

10x Genomics, under the leadership of co-founder and CEO Serge Saxonov, PhD, is making a strategic shift towards enhancing customer support and expanding its presence in the biopharma market. Following a prolific year of product launches in 2024, the company is now focusing on promoting its recent

Telehealth Companies Increase Ads While Expanding Into Complex Care
Tech & Innovation Telehealth Companies Increase Ads While Expanding Into Complex Care

Telehealth companies are making significant strides in the healthcare industry by ramping up their advertising efforts and expanding into more complex areas of medicine. Initially known for providing low-stigma, easily accessible health products, these companies are now venturing into fields such

Bio-Rad Introduces TrailBlazer Kits for Advanced Antibody Labeling
Biotech & Bioprocessing Bio-Rad Introduces TrailBlazer Kits for Advanced Antibody Labeling

In a significant development for the scientific community, Bio-Rad Laboratories, Inc., a front-runner in life science research and clinical diagnostics products, unveiled its innovative TrailBlazer™ Tag and TrailBlazer StarBright™ Dye Label Kits. These advanced kits offer a seamless method for res

Sphere Fluidics Introduces Cyto-Mine Chroma with Early Access Program
Biotech & Bioprocessing Sphere Fluidics Introduces Cyto-Mine Chroma with Early Access Program

Sphere Fluidics has made strides in biotechnology by unveiling its innovative Cyto-Mine® Chroma at the SLAS2025 International Conference and Exhibition recently held in San Diego, California. This cutting-edge iteration of their well-established Cyto-Mine platform is primed to revolutionize

Should the US Create a Unified National Biosafety and Biosecurity Agency?
Biotech & Bioprocessing Should the US Create a Unified National Biosafety and Biosecurity Agency?

The memorandum to President Trump suggests addressing the significant need for a cohesive strategy to manage biological risks through the establishment of a Unified National Biosafety and Biosecurity Agency. The driving factor behind this proposal is the potential for high-risk laboratory research

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later